<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="due to coronaviruses. Several pre-existing and potential drug candidates, including" exact="chloroquine" post="and remdesivir, have been considered [10], [11], [12]. The"/>
 <result pre="including favipiravir, ribavirin, penciclovir, galidesivir, remdesivir, 6′-fluorinated aristeromycin analogues and" exact="acyclovir" post="fleximer analogues [12]. Remdesivir (GS-5734), the phosphoramidate prodrug of"/>
 <result pre="fleximer analogues [12]. Remdesivir (GS-5734), the phosphoramidate prodrug of an" exact="adenosine" post="C‑nucleoside [13], has a similar structure to tenofovir alafenamide,"/>
 <result pre="of an adenosine C‑nucleoside [13], has a similar structure to" exact="tenofovir alafenamide," post="which is a nucleotide analogue of adenosine 5-monophosphate with"/>
 <result pre="structure to tenofovir alafenamide, which is a nucleotide analogue of" exact="adenosine" post="5-monophosphate with antiviral activity against hepatitis B virus and"/>
 <result pre="demonstrated that nucleoside triphosphate works as an incorporation competitor with" exact="adenosine" post="triphosphate, confuses viral RdRp, acts as a delayed RNA"/>
 <result pre="and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f] [triazin-4-amino]" exact="adenine" post="c-nucleoside (GS-5734) for the treatment of Ebola and emerging"/>
 <result pre="the viral polymerase and the proofreading exoribonucleasemBio9201810.1128/mBio.00221-18pii: e00221-18 18WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
</results>
